Chinook Therapeutics, Inc. (KDNY) Social Stream
CHINOOK THERAPEUTICS INC (KDNY) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering KDNY.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 7 | $40 | $25 | $33.166 | $40.39 | -17.89% |
| 2021-11-15 | 6 | $40 | $25 | $33 | $40.39 | -18.3% |
| 2022-01-26 | 6 | $40 | $25 | $31.166 | $40.39 | -22.84% |
| 2022-03-22 | 6 | $40 | $25 | $31.333 | $40.39 | -22.42% |
| 2022-05-05 | 7 | $40 | $25 | $31.333 | $40.39 | -22.42% |
| 2022-05-19 | 7 | $40 | $25 | $31.5 | $40.39 | -22.01% |
| 2022-05-20 | 7 | $48 | $25 | $32.833 | $40.39 | -18.71% |
| 2022-05-23 | 7 | $48 | $28 | $35.666 | $40.39 | -11.7% |
| 2022-05-24 | 7 | $48 | $28 | $36.5 | $40.39 | -9.63% |
| 2022-06-01 | 7 | $48 | $28 | $36.166 | $40.39 | -10.46% |
| 2022-08-10 | 8 | $48 | $28 | $35.285 | $40.39 | -12.64% |
| 2022-09-30 | 7 | $48 | $28 | $35.857 | $40.39 | -11.22% |
| 2022-11-13 | 7 | $51 | $28 | $36.285 | $40.39 | -10.16% |
| 2022-11-17 | 8 | $51 | $28 | $36.285 | $40.39 | -10.16% |
| 2022-11-23 | 8 | $51 | $28 | $36.428 | $40.39 | -9.81% |
| 2022-12-05 | 9 | $51 | $28 | $35.625 | $40.39 | -11.8% |
| 2023-02-20 | 9 | $51 | $28 | $37.25 | $40.39 | -7.77% |
| 2023-02-28 | 9 | $51 | $30 | $37.875 | $40.39 | -6.23% |
| 2023-04-12 | 11 | $51 | $30 | $38.6 | $40.39 | -4.43% |
| 2023-05-10 | 11 | $51 | $30 | $37.8 | $40.39 | -6.41% |
| 2023-06-08 | 11 | $51 | $30 | $37.9 | $40.39 | -6.16% |
| 2023-06-11 | 10 | $51 | $30 | $38.333 | $40.39 | -5.09% |
| 2023-06-13 | 10 | $47 | $30 | $39 | $40.39 | -3.44% |
| 2023-07-11 | 11 | $47 | $30 | $40.1 | $40.39 | -0.72% |
| 2023-08-01 | 11 | $47 | $40 | $41.1 | $40.39 | 1.76% |
| 2023-08-08 | 11 | $47 | $40 | $41.1 | $40.39 | 1.76% |
The Trend in the Analyst Price Target
Over the past 17 months, KDNY's average price target has gone up $9.77.
Over the past 51 weeks, KDNY's average upside potential has been 57.41%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-04 | 7 | 51 | 28 | 36.285 | 21.74 | 66.9% |
| 2023-03-01 | 10 | 51 | 30 | 38.333 | 22.95 | 67.03% |
| 2023-06-08 | 11 | 51 | 30 | 37.900 | 23.95 | 58.25% |
| 2023-06-11 | 10 | 51 | 30 | 38.333 | 23.99 | 59.79% |
| 2023-06-13 | 10 | 47 | 30 | 39.000 | 37.87 | 2.98% |
KDNY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.82 | 1 | 0 | 10 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
Over the past 39 weeks, KDNY's average broker recommendation rating worsened by 1.67.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KDNY as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, CHINOOK THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 299.12% of them.
- In terms of how CHINOOK THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1624.97% of that group.
- In terms of how CHINOOK THERAPEUTICS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 1574.16% of that group.
- In the context of Pharmaceutical Products stocks, CHINOOK THERAPEUTICS INC's average analyst price target is greater than 1647.4% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CHINOOK THERAPEUTICS INC are XNCR, PAHC, and RVNC.
View All Top Stocks by Price Target
Make investment decisions regarding KDNY using the data that counts. Try POWR Ratings for free.